BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• FDA

  Neovasc Inc. Receives CE Mark for Reducer(TM) Product to Treat Refractory Angina

  November 14, 2011

   · 

  6 min read
• Business

  ThermalTherapeuticSystems Names Gardiner F. H. Smith, President and Chief Executive Officer

  November 14, 2011

   · 

  2 min read
• Deals

  FEI Company Acquires TILL Photonics in $20 Million Deal

  November 14, 2011

   · 

  2 min read
• Drug Development

  Merck & Co., Inc.'s Anti-Clotting Drug Flops in Key Trial

  November 14, 2011

   · 

  1 min read
• Bio NC

  Targacept, Inc. to Present at the Lazard Capital Markets 8th Annual Healthcare Conference

  November 14, 2011

   · 

  1 min read
• Drug Development

  Johnson & Johnson, Bayer AG Anticlotting Drug Shows Promise in Heart-Attack Patients

  November 14, 2011

   · 

  13 min read
• WuXi PharmaTech Co., Ltd. to Form $50 Million Venture Fund

  November 14, 2011

   · 

  1 min read
• BioCapital

  Another FDA Rejection for Alimera Sciences Eye Drug

  November 14, 2011

   · 

  1 min read
• Policy

  Merck & Co., Inc. CEO to Head Penn State University Abuse Probe

  November 14, 2011

   · 

  1 min read
• Drug Development

  Genzyme Corporation MS Drug Significantly Reduces Relapse, Disability in Phase III Trial

  November 14, 2011

   · 

  11 min read